Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

KT/V: the denominator dilemma.

Bengt Lindholm1, Jacek Waniewski, Andrzej Weryński

  • 1Divisions of Baxter Novum and Renal Medicine, Karolinska Institutet, Stockholm, Sweden. bengt.lindholm@klinvet.ki.se

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 21, 2004
PubMed
Summary

The commonly used KT/V index for dialysis efficacy is confusing because it has different meanings in hemodialysis (HD) and peritoneal dialysis (PD). This hinders direct comparison of dialysis effectiveness between these treatment modalities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023
Same author

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients.

American journal of nephrology·2023
Same author

GLIM in chronic kidney disease: What do we need to know?

Clinical nutrition (Edinburgh, Scotland)·2023
Same author

Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.

Scientific reports·2023
Same author

Resolved: Being Fat Is Good for Dialysis Patients: The Godzilla Effect: Con.

Journal of the American Society of Nephrology : JASN·2023
Same author

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients.

Frontiers in nutrition·2023

Area of Science:

  • Nephrology
  • Biomedical Engineering

Background:

  • The KT/V index is widely used to assess solute removal in renal replacement therapy.
  • Significant differences exist in the calculation and interpretation of KT/V between hemodialysis (HD) and peritoneal dialysis (PD).

Purpose of the Study:

  • To highlight the shortcomings of the KT/V concept for comparing dialysis efficacy between HD and PD.
  • To address the confusion arising from the disparate application of KT/V in different dialysis modalities.
  • To discuss the implications of using the distribution volume (V) as a denominator when V itself is a predictor of patient survival.

Main Methods:

  • Review of existing literature and definitions of KT/V in HD and PD.
  • Analysis of the components of KT/V (K, T, V) and their variations across dialysis types.

Related Experiment Videos

  • Examination of the clinical relevance of KT/V in predicting outcomes, referencing studies like ADEMEX and HEMO.

    • Main Results:

    • KT/V calculations and interpretations differ significantly between HD and PD, making direct comparisons invalid.
    • The time (T) and distribution volume (V) components of KT/V are calculated differently, further complicating comparisons.
    • The distribution volume (V) is a strong predictor of survival, independent of dialysis dose, which complicates the interpretation of KT/V.

    Conclusions:

    • The current KT/V metric is inadequate for directly comparing dialysis dose and efficacy between HD and PD.
    • Clinical outcome studies may fail to show strong impacts of KT/V variations due to inherent differences in its calculation and the prognostic value of V.
    • A revised approach is needed to accurately assess and compare dialysis adequacy across different renal replacement therapies.